This article was originally published in The Gray Sheet
Executive SummaryIntroduces three wands for removing or shrinking tissue during arthroscopic joint surgery. The CoVac adds a suction feature to tissue removal and hemostasis and will allow surgeons to perform the procedure using a single instrument, the company says. The Saber, ArthoCare's first ArthroWand designed for cutting and removal of tissue along the entire length of the electrode, is expected to be used primarily for lateral release procedures in the knee and for releasing frozen shoulders. A third product, the Eliminator, has a broad brush-like design and larger electrode surface for "very rapid tissue removal and enhanced coagulation," and will be helpful in knee surgeries that involve reconstruction of the anterior cruciate ligament and sculpting of cartilage
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.